Abeona Therapeutics Inc.ABEONASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-58.46M
↓ 39% below average
Average (9y)
$-42.16M
Historical baseline
Range
High:$-10.73M
Low:$-69.82M
CAGR
+20.7%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-58.46M | -56.6% |
| 2023 | $-37.34M | +14.4% |
| 2022 | $-43.61M | +37.5% |
| 2021 | $-69.82M | -92.0% |
| 2020 | $-36.35M | +47.6% |
| 2019 | $-69.33M | -18.3% |
| 2018 | $-58.60M | -146.3% |
| 2017 | $-23.80M | -75.8% |
| 2016 | $-13.53M | -26.1% |
| 2015 | $-10.73M | - |